Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Cancer incidence in an Austrian alpine valley 1983-2012 : A descriptive study.

Hutter HP, Waldhoer T, Müller K, Hackl M, Weitensfelder L, Heinzl H.

Wien Klin Wochenschr. 2019 Mar 14. doi: 10.1007/s00508-019-1476-7. [Epub ahead of print]

PMID:
30874891
2.

Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991-2010 (Automated Childhood Cancer Information System): a population-based study.

Steliarova-Foucher E, Fidler MM, Colombet M, Lacour B, Kaatsch P, Piñeros M, Soerjomataram I, Bray F, Coebergh JW, Peris-Bonet R, Stiller CA; ACCIS contributors.

Lancet Oncol. 2018 Sep;19(9):1159-1169. doi: 10.1016/S1470-2045(18)30423-6. Epub 2018 Aug 8.

3.

Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference.

Nicolai N, Biasoni D, Catanzaro MA, Colecchia M, Trama A; RARECAREnet Working Group.

Eur J Surg Oncol. 2019 Jan;45(1):60-66. doi: 10.1016/j.ejso.2018.02.006. Epub 2018 Feb 14. Review.

PMID:
29526370
4.

Treatment challenges in and outside a network setting: Head and neck cancers.

Orlandi E, Alfieri S, Simon C, Trama A, Licitra L; RARECAREnet Working Group.

Eur J Surg Oncol. 2019 Jan;45(1):40-45. doi: 10.1016/j.ejso.2018.02.007. Epub 2018 Feb 14. Review.

PMID:
29478741
5.

Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting.

Imbimbo M, Maury JM, Garassino M, Girard N; RARECAREnet Working Group.

Eur J Surg Oncol. 2019 Jan;45(1):75-80. doi: 10.1016/j.ejso.2018.01.078. Epub 2018 Feb 2.

PMID:
29426781
6.

Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours.

Lykoudis PM, Partelli S, Muffatti F, Caplin M, Falconi M, Fusai GK; RARECARENet Working Group.

Eur J Surg Oncol. 2019 Jan;45(1):46-51. doi: 10.1016/j.ejso.2017.08.019. Epub 2017 Oct 16. Review.

PMID:
29126671
7.

Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting.

Ray-Coquard I, Trama A, Seckl MJ, Fotopoulou C, Pautier P, Pignata S, Kristensen G, Mangili G, Falconer H, Massuger L, Sehouli J, Pujade-Lauraine E, Lorusso D, Amant F, Rokkones E, Vergote I, Ledermann JA; RARECARENet Working Group.

Eur J Surg Oncol. 2019 Jan;45(1):67-74. doi: 10.1016/j.ejso.2017.09.025. Epub 2017 Nov 3. Review.

PMID:
29108961
8.

Epidemiology of rare cancers and inequalities in oncologic outcomes.

Gatta G, Trama A, Capocaccia R; RARECARENet Working Group.

Eur J Surg Oncol. 2019 Jan;45(1):3-11. doi: 10.1016/j.ejso.2017.08.018. Epub 2017 Sep 19.

PMID:
29032924
9.

Treatment challenges in and outside a network setting: Soft tissue sarcomas.

Pasquali S, Bonvalot S, Tzanis D, Casali PG, Trama A, Gronchi A; RARECARENet Working Group.

Eur J Surg Oncol. 2019 Jan;45(1):31-39. doi: 10.1016/j.ejso.2017.09.015. Epub 2017 Sep 19.

PMID:
28985973
10.

Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study.

Gatta G, Capocaccia R, Botta L, Mallone S, De Angelis R, Ardanaz E, Comber H, Dimitrova N, Leinonen MK, Siesling S, van der Zwan JM, Van Eycken L, Visser O, Žakelj MP, Anderson LA, Bella F, Kaire I, Otter R, Stiller CA, Trama A; RARECAREnet working group.

Lancet Oncol. 2017 Aug;18(8):1022-1039. doi: 10.1016/S1470-2045(17)30445-X. Epub 2017 Jul 4. Erratum in: Lancet Oncol. 2017 Aug;18(8):e433.

PMID:
28687376
11.

Trends in incidence, survival and mortality of childhood and adolescent cancer in Austria, 1994-2011.

Karim-Kos HE, Hackl M, Mann G, Urban C, Woehrer A, Slavc I, Ladenstein R.

Cancer Epidemiol. 2016 Jun;42:72-81. doi: 10.1016/j.canep.2016.03.015. Epub 2016 Apr 4.

PMID:
27054577
12.

Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases.

Berghoff AS, Fuchs E, Ricken G, Mlecnik B, Bindea G, Spanberger T, Hackl M, Widhalm G, Dieckmann K, Prayer D, Bilocq A, Heinzl H, Zielinski C, Bartsch R, Birner P, Galon J, Preusser M.

Oncoimmunology. 2015 Jun 9;5(1):e1057388. eCollection 2016.

13.

The burden of malignant melanoma--lessons to be learned from Austria.

Monshi B, Vujic M, Kivaranovic D, Sesti A, Oberaigner W, Vujic I, Ortiz-Urda S, Posch C, Feichtinger H, Hackl M, Rappersberger K.

Eur J Cancer. 2016 Mar;56:45-53. doi: 10.1016/j.ejca.2015.11.026. Epub 2016 Jan 20.

14.

Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: Results of EUROCARE-5.

Lepage C, Capocaccia R, Hackl M, Lemmens V, Molina E, Pierannunzio D, Sant M, Trama A, Faivre J; EUROCARE-5 Working Group:.

Eur J Cancer. 2015 Oct;51(15):2169-2178. doi: 10.1016/j.ejca.2015.07.034. Epub 2015 Sep 26.

PMID:
26421820
15.

On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999-2007 - Results from the EUROCARE-5 study.

Holleczek B, Rossi S, Domenic A, Innos K, Minicozzi P, Francisci S, Hackl M, Eisemann N, Brenner H; EUROCARE-5 Working Group:.

Eur J Cancer. 2015 Oct;51(15):2158-2168. doi: 10.1016/j.ejca.2015.07.024. Epub 2015 Sep 26.

PMID:
26421819
16.

Suicide among 915,303 Austrian cancer patients: who is at risk?

Vyssoki B, Gleiss A, Rockett IR, Hackl M, Leitner B, Sonneck G, Kapusta ND.

J Affect Disord. 2015 Apr 1;175:287-91. doi: 10.1016/j.jad.2015.01.028. Epub 2015 Jan 23.

PMID:
25661393
17.

Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases.

Berghoff AS, Ilhan-Mutlu A, Dinhof C, Magerle M, Hackl M, Widhalm G, Hainfellner JA, Dieckmann K, Pichler J, Hutterer M, Melchardt T, Bartsch R, Zielinski CC, Birner P, Preusser M.

Neuropathol Appl Neurobiol. 2015 Feb;41(2):e41-55. doi: 10.1111/nan.12185.

PMID:
25256708
18.

Amplification and overexpression of CMET is a common event in brain metastases of non-small cell lung cancer.

Preusser M, Streubel B, Berghoff AS, Hainfellner JA, von Deimling A, Widhalm G, Dieckmann K, Wöhrer A, Hackl M, Zielinski C, Birner P.

Histopathology. 2014 Nov;65(5):684-92. doi: 10.1111/his.12475. Epub 2014 Aug 5.

PMID:
25039982
19.

High rate of FGFR1 amplifications in brain metastases of squamous and non-squamous lung cancer.

Preusser M, Berghoff AS, Berger W, Ilhan-Mutlu A, Dinhof C, Widhalm G, Dieckmann K, Wöhrer A, Hackl M, von Deimling A, Streubel B, Birner P.

Lung Cancer. 2014 Jan;83(1):83-9. doi: 10.1016/j.lungcan.2013.10.004. Epub 2013 Oct 17.

PMID:
24183471
20.

Frequent overexpression of ErbB--receptor family members in brain metastases of non-small cell lung cancer patients.

Berghoff AS, Magerle M, Ilhan-Mutlu A, Dinhof C, Widhalm G, Dieckman K, Marosi C, Wöhrer A, Hackl M, Zöchbauer-Müller S, Preusser M, Birner P.

APMIS. 2013 Dec;121(12):1144-52. doi: 10.1111/apm.12063. Epub 2013 Jun 12.

PMID:
23756255
21.

ALK gene translocations and amplifications in brain metastases of non-small cell lung cancer.

Preusser M, Berghoff AS, Ilhan-Mutlu A, Magerle M, Dinhof C, Widhalm G, Dieckmann K, Marosi C, Wöhrer A, Hackl M, Zöchbauer-Müller S, von Deimling A, Schoppmann SF, Zielinski CC, Streubel B, Birner P.

Lung Cancer. 2013 Jun;80(3):278-83. doi: 10.1016/j.lungcan.2013.01.019. Epub 2013 Feb 27.

PMID:
23453647
22.

Preoperative diffusion-weighted imaging of single brain metastases correlates with patient survival times.

Berghoff AS, Spanberger T, Ilhan-Mutlu A, Magerle M, Hutterer M, Woehrer A, Hackl M, Widhalm G, Dieckmann K, Marosi C, Birner P, Prayer D, Preusser M.

PLoS One. 2013;8(2):e55464. doi: 10.1371/journal.pone.0055464. Epub 2013 Feb 5.

23.

Extent of peritumoral brain edema correlates with prognosis, tumoral growth pattern, HIF1a expression and angiogenic activity in patients with single brain metastases.

Spanberger T, Berghoff AS, Dinhof C, Ilhan-Mutlu A, Magerle M, Hutterer M, Pichler J, Wöhrer A, Hackl M, Widhalm G, Hainfellner JA, Dieckmann K, Marosi C, Birner P, Prayer D, Preusser M.

Clin Exp Metastasis. 2013 Apr;30(4):357-68. doi: 10.1007/s10585-012-9542-9. Epub 2012 Oct 17.

PMID:
23076770
24.

Estimation of completeness of case ascertainment of Austrian cancer incidence data using the flow method.

Hackl M, Waldhoer T.

Eur J Public Health. 2013 Oct;23(5):889-93. doi: 10.1093/eurpub/cks125. Epub 2012 Sep 22.

PMID:
23002230
25.

Smoking and lung cancer: current trends in Austria.

Thompson CA, Waldhör T, Schernhammer ES, Hackl M, Vutuc C, Haidinger G.

Wien Klin Wochenschr. 2012 Aug;124(15-16):493-9. Epub 2012 Jul 20.

26.

Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases.

Capper D, Berghoff AS, Magerle M, Ilhan A, Wöhrer A, Hackl M, Pichler J, Pusch S, Meyer J, Habel A, Petzelbauer P, Birner P, von Deimling A, Preusser M.

Acta Neuropathol. 2012 Feb;123(2):223-33. doi: 10.1007/s00401-011-0887-y. Epub 2011 Oct 20.

PMID:
22012135
27.

Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study.

Brenner H, Bouvier AM, Foschi R, Hackl M, Larsen IK, Lemmens V, Mangone L, Francisci S; EUROCARE Working Group.

Int J Cancer. 2012 Oct 1;131(7):1649-58. doi: 10.1002/ijc.26192. Epub 2011 Aug 3.

28.

Manual for coding and reporting haematological malignancies.

HAEMACARE Working Group.

Tumori. 2010 Jul-Aug;96(4):i-A32. No abstract available.

PMID:
20968151
29.
30.

The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry.

Wöhrer A, Waldhör T, Heinzl H, Hackl M, Feichtinger J, Gruber-Mösenbacher U, Kiefer A, Maier H, Motz R, Reiner-Concin A, Richling B, Idriceanu C, Scarpatetti M, Sedivy R, Bankl HC, Stiglbauer W, Preusser M, Rössler K, Hainfellner JA.

J Neurooncol. 2009 Dec;95(3):401-411. doi: 10.1007/s11060-009-9938-9. Epub 2009 Jun 28.

PMID:
19562257
31.

Survival of patients with colorectal cancer in Austria by sex, age, and stage.

Haidinger G, Waldhoer T, Hackl M, Vutuc C.

Wien Med Wochenschr. 2006 Oct;156(19-20):549-51.

PMID:
17103293

Supplemental Content

Loading ...
Support Center